Literature DB >> 10882089

Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice.

Motomichi Takahashi1, Haruhiko Taguchi1, Hiroyuki Yamaguchi1, Takako Osaki1, Shigeru Kamiya1.   

Abstract

The interaction between Clostridium butyricum and Helicobacter pylori was examined in vitro and in vivo. The culture supernate of C. butyricum MIYAIRI 588 inhibited the growth of H. pylori even when its pH was adjusted to 7.4. The bactericidal effect of butyric acid on H. pylori was stronger than that of lactic, acetic or hydrochloric acids. Flow cytometric analysis showed that pre-incubation of gastric epithelial (MKN45) cells with H. pylori and C. butyricum inhibited the adhesion of H. pylori to the cells. Persistent infection with H. pylori in the gastric mucosa of germ-free mice was observed for 5 weeks. Cure of persistent infection with H. pylori in the gnotobiotic mice was demonstrated following infection with C. butyricum. The probiotic agent, C. butyricum MIYAIRI 588 may have some beneficial effects on H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882089     DOI: 10.1099/0022-1317-49-7-635

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

Review 1.  Current progress on butyric acid production by fermentation.

Authors:  Chunhui Zhang; Hua Yang; Fangxiao Yang; Yujiu Ma
Journal:  Curr Microbiol       Date:  2009-08-29       Impact factor: 2.188

2.  Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Authors:  Dionyssios N Sgouras; Effrosini G Panayotopoulou; Beatriz Martinez-Gonzalez; Kalliopi Petraki; Spyros Michopoulos; Andreas Mentis
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

3.  Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials.

Authors:  Yi Gong; Yan Li; Qian Sun
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice.

Authors:  Fang-Yan Wang; Jia-Ming Liu; Hai-Hua Luo; Ai-Hua Liu; Yong Jiang
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

5.  Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome.

Authors:  Tadashi Yamaguchi; Shoji Tsuji; Shohei Akagawa; Yuko Akagawa; Jiro Kino; Sohsaku Yamanouchi; Takahisa Kimata; Masaki Hashiyada; Atsushi Akane; Kazunari Kaneko
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

6.  Biotechnological potential of Clostridium butyricum bacteria.

Authors:  Daria Szymanowska-Powałowska; Dorota Orczyk; Katarzyna Leja
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

Review 7.  Effect of Clostridium butyricum on Gastrointestinal Infections.

Authors:  Tadashi Ariyoshi; Mao Hagihara; Motomichi Takahashi; Hiroshige Mikamo
Journal:  Biomedicines       Date:  2022-02-18

8.  Growth Limiting pH, Water Activity, and Temperature for Neurotoxigenic Strains of Clostridium butyricum.

Authors:  Hamid B Ghoddusi; Richard E Sherburn; Olusimbo O Aboaba
Journal:  ISRN Microbiol       Date:  2013-09-30

9.  The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial.

Authors:  Luyi Chen; Wenli Xu; Allen Lee; Jiamin He; Bixia Huang; Wenfang Zheng; Tingting Su; Sanchuan Lai; Yanqin Long; Hua Chu; Yujia Chen; Lan Wang; Kan Wang; Jianmin Si; Shujie Chen
Journal:  EBioMedicine       Date:  2018-08-23       Impact factor: 8.143

10.  Establishment of an Endogenous Clostridium difficile Rat Infection Model and Evaluation of the Effects of Clostridium butyricum MIYAIRI 588 Probiotic Strain.

Authors:  Kentaro Oka; Takako Osaki; Tomoko Hanawa; Satoshi Kurata; Emi Sugiyama; Motomichi Takahashi; Mamoru Tanaka; Haruhiko Taguchi; Shigeru Kamiya
Journal:  Front Microbiol       Date:  2018-06-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.